Science Current Events | Science News | Brightsurf.com
 

Study offers new way to discover HIV vaccine targets

March 22, 2013

Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development

Decades of research and three large-scale clinical trials have so far failed to yield an effective HIV vaccine, in large part because the virus evolves so rapidly that it can evade any vaccine-induced immune response.

Researchers from the Ragon Institute of MGH, MIT and Harvard University have now developed a new approach to vaccine design that may allow them to cut off those evolutionary escape routes. The researchers have developed and experimentally validated a computational method that can analyze viral protein sequences to determine how well different viral strains can reproduce in the body. That knowledge gives researchers an unprecedented guide for identifying viral vulnerabilities that could be exploited to design successful vaccine targets.

The team, led by Arup Chakraborty, the Robert T. Haslam Professor of Chemical Engineering, Chemistry, Physics and Biological Engineering at MIT, has designed protein fragments (peptides) that would target these weaknesses. Ragon Institute researchers are now developing ways to deliver the peptides so they can be tested in animals.

"We think that, if it continues to be validated against laboratory and clinical data, this method could be quite useful for rational design of the active component of a vaccine for diverse viruses. Furthermore, if delivered properly, the peptides we have designed may be able to mount potent responses against HIV across a population," says Chakraborty, who is also the director of MIT's Institute for Medical Engineering and Science.

Chakraborty and his colleagues describe their findings in the March 21 issue of the journal Immunity. Lead author of the paper is Andrew Ferguson, a former postdoc in Chakraborty's lab who is now an assistant professor at the University of Illinois at Urbana-Champaign. Other authors are Bruce Walker, director of the Ragon Institute and a professor at Harvard Medical School; Thumbi Ndung'u of the Ragon Institute and the Doris Duke Medical Research Institute in South Africa; and Jaclyn Mann and Saleha Omarjee of the Doris Duke Medical Research Institute.

"This work stems from the novel approach to science that is the central mission of the Ragon Institute: to draw researchers from diverse scientific disciplines to catalyze new advances, the ultimate mission being to harness the immune system to prevent and cure human diseases," Walker says.

Rapid evolution

Typically when a vaccine for a disease such as smallpox or polio is given, exposure to viral fragments primes the body's immune system to respond powerfully if it encounters the real virus. With HIV, it appears that when immune cells in a vaccinated person attack viral peptides that they recognize, the virus quickly mutates its protein sequences so immune cells no longer recognize them.

To overcome this, scientists have tried analyzing viral proteins to find amino acids that don't often mutate, which would suggest that they are critical to the virus's survival. However, this approach ignores the fact that mutations elsewhere in the protein can compensate when those seemingly critical amino acids are forced to evolve, Chakraborty says.

The Ragon Institute team focused on defining how the virus's ability to survive depends on the sequences of its proteins, if they have multiple mutations. This knowledge could enable identification of combinations of amino acid mutations that are harmful to the virus. Vaccines that target those amino acids would force the virus to make mutations that weaken it.

With existing HIV protein sequence data as input, the researchers created a computer model that can predict the fitness of any possible sequence, enabling prediction of how specific mutations would affect the virus.

In this paper, the researchers focused on an HIV polyprotein called Gag, which is made up of several proteins that together are 500 amino acids long. The proteins derived from Gag are important structural elements of the virus. For example, a protein called p24 makes up the capsid that surrounds the virus's genetic material.

Each position in HIV proteins can be occupied by one of 20 possible amino acids. Sequence data from thousands of different HIV strains contain information on the likelihood of mutations at each position and each pair of positions, as well as for triplets and larger groups. The researchers then developed a computer model based on spin glass models, originally developed in physics, to translate this information into predictions for the prevalence of any mutant.

Using this model, the researchers can enter any possible sequence of Gag proteins and determine how prevalent it will be. That prevalence correlates with the fitness of a virus carrying that particular protein sequence, a relationship that the researchers demonstrated by using the model to predict the fitness of a few dozen Gag protein sequences, and verified by engineering those sequences into HIV viruses and testing their ability to replicate in cells grown in the lab. They also tested their predictions against human clinical data.

Visualizing fitness

The model also allows the researchers to visualize viral fitness using "fitness landscapes" - topographical maps that show how fit the virus is for different possible amino-acid sequences for the Gag proteins. In these landscapes, each hill represents sequences that are very fit; valleys represent sequences that are not.

Ideally, vaccine-induced immune responses would target viral proteins in such a way that mutant strains that escape the immune response correspond to the fitness valleys. Thus, the virus would either be destroyed by the immune response or forced to mutate to strains that cannot replicate well and are less able to infect more cells.

This would mimic the immune response mounted by people known as "elite controllers," who are exposed to the virus but able to control it without medication. Immune cells in those people target the same peptide sequences that the model predicted would produce the biggest loss of fitness when mutated.

This general approach could also be used to identify vaccine targets for other viruses, Chakraborty says.

"The reason we are excited about this is that we now have a method that combines two technologies that are getting cheaper all the time: sequencing and computation," he says. "We think that if this continues to be validated, it could become a general method of obtaining the fitness landscapes of viruses, allowing you to do rational design of the active components of vaccines."

"This work is a great example of how integrating expertise from different scientific disciplines - in this case physics, computational biology, virology and immunology - can accelerate progress toward an HIV vaccine," Walker says.

Massachusetts Institute of Technology


Related Immune Response Current Events and Immune Response News Articles


New blood test for the detection of bovine TB
A new blood test to detect Mycobacteria in blood has been developed by a team at The University of Nottingham led by Dr Cath Rees, an expert in microbiology in the School of Biosciences and Dr Ben Swift from the School of Veterinary Medicine and Science.

Tobacco smoke makes germs more resilient
The mouth is one of the "dirtiest" parts of the body, home to millions of germs. But puffing cigarettes can increase the likelihood that certain bacteria like Porphyromonas gingivalis will not only set up camp but will build a fortified city in the mouth and fight against the immune system.

Zika virus infects human placental macrophages
One of Zika's mysteries is how the virus passes from an infected mother, through the placenta, to a developing fetus.

A combined approach to treating metastatic melanoma
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy.

Potential impact of a dengue vaccine in the Yucatan
While no dengue vaccine has yet been approved for general use, several candidates are in clinical development.

Can Alzheimer's disease-associated peptide fight bacterial infection?
Amyloid-ß is a sticky peptide notorious for forming destructive plaques in the brains of Alzheimer's disease patients, but a new study suggests that it may also serve a protective function as an antimicrobial peptide.

Researchers make a key discovery in how malaria evades the immune system
The malaria parasite Plasmodium falciparum hijacks an immune system process to invade red blood cells, according to a study led by researchers at Penn State College of Medicine. Understanding how malaria invades the cells could lead to a more effective vaccine.

Study reveals protein that dials immune responses up and down
Research led by scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) has identified a new regulator of immune responses.

Nanoscale Trojan horses treat inflammation
Nanosized Trojan horses created from a patient's own immune cells have successfully treated inflammation by overcoming the body's complex defense mechanisms, perhaps leading to broader applications for treating diseases characterized by inflammation, such as cancer and cardiovascular diseases.

Flu vaccination associated with lower dementia risk in patients with heart failure
Influenza vaccination is associated with a lower risk of dementia in patients with heart failure, according to a study in more than 20 000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr Ju-Chi Liu, director of the Division of Cardiovascular Medicine, Department of Medicine, Taipei Medical University - Shuang Ho Hospital, in New Taipei City, Taiwan.
More Immune Response Current Events and Immune Response News Articles

Immune Response

Immune Response


On the wet Olympic peninsula of Washington state. Physician's Assistant Rick scales is having problems with some of his terminally-ill patients– –they aren't dying … Along with Makah tribal cop Jasmine Hughes, Scales starts to poke around, and they find way more than they expected. A classic medical mystery, from New York Times Bestselling author Steve Perry.

Autophagy, Infection, and the Immune Response

Autophagy, Infection, and the Immune Response
by William T. Jackson (Editor), Michele Swanson (Editor)


The relationship between infection and immunity and autophagy, a pathway of cellular homeostasis and stress response, has been a rapidly growing field of study over the last decade. While some cellular processes are pro- or anti-infection, autophagy has been proven to be both: a part of the innate immune response against some microbes, and a cellular pathway subverted by some pathogens to promote their own replication.

Autophagy, Infection, and the Immune Response provides a unified overview of the roles of cellular autophagy during microbial infection. Introductory chapters ground the reader by delineating the autophagic pathway from a cellular perspective, and by listing assays available for measuring autophagy. Subsequent chapters address virus interactions with...

Immune Response and the Eye (Chemical Immunology and Allergy, Vol. 92)

Immune Response and the Eye (Chemical Immunology and Allergy, Vol. 92)
by J.Y. Niederkorn (Editor), H.J. Kaplan (Editor), H. Renz (Editor)


The second edition of Immune ‘Response and the Eye’ highlights recent insights into the ‘dangerous compromise’ between the immune system and the eye, which protects the eye against pathogens while limiting inflammation and immune-mediated injury to ocular tissues with little or no regenerative potential. It discusses the broad spectrum of physiological, immunological, anatomical, and biochemical adaptations that conspire to closely regulate the tone and tenor of immune responses in the eye. This volume further describes immune-mediated diseases that occur when the compromise between the immune system and the eye is breached. This breakdown in immune privilege threatens the vision of millions each year. Finally, recent advances in ocular immunology are presented, which offer...

The Cytokines of the Immune System: The Role of Cytokines in Disease Related to Immune Response

The Cytokines of the Immune System: The Role of Cytokines in Disease Related to Immune Response
by Zlatko Dembic (Author)


The Cytokines of the Immune System catalogs cytokines and links them to physiology and pathology, providing a welcome and hugely timely tool for scientists in all related fields. In cataloguing cytokines, it lists their potential for therapeutic use, links them to disease treatments needing further research and development, and shows their utility for learning about the immune system. This book offers a new approach in the study of cytokines by combining detailed guidebook-style cytokine description, disease linking, and presentation of immunologic roles.Supplies new ideas for basic and clinical researchProvides cytokine descriptions in a guidebook-style, cataloging the origins, structures, functions, receptors, disease-linkage, and therapeutic potentialsOffers a textbook-style view on...

The Immune Response to Implanted Materials and Devices: The Impact of the Immune System on the Success of an Implant

The Immune Response to Implanted Materials and Devices: The Impact of the Immune System on the Success of an Implant
by Bruna Corradetti (Editor)


This book provides a comprehensive overview of the cascade of events activated in the body following the implant of biomaterials and devices. It is one of the first books to shed light on the role of the host immune response on therapeutic efficacy, and reviews the state-of-the-art for both basic science and medical applications. The text examines advantages and disadvantages of the use of synthetic versus natural biomaterials. Particular emphasis is placed on the role of biomimicry in the development of smart strategies able to modulate infiltrating immune cells, thus reducing side effects (such as acute and chronic inflammation, fibrosis and/or implant rejection) and improving the therapeutic outcome (healing, tissue restoration). Current cutting-edge approaches in tissue engineering,...

The Immune Response to Infection

The Immune Response to Infection
by Stefan H. E. Kaufmann (Editor), Barry T. Rouse (Editor), David L. Sacks (Editor)


Examines the mechanisms of both the innate and adaptive immune systems as they relate to infection and disease. Explores the underlying mechanisms of immunity and the many sequelae of host-pathogen interactions, ranging from the sterile eradication of the invader, to controlled chronic infection, to pathologic corollaries of the host-pathogen crosstalk. Discusses the pathogenesis of certain autoimmune disorders and cancers that are induced by infectious agents but then become independent of the infection process. Serves as a resource for immunologists, molecular microbiologists, infectious disease clinicians, researchers, and students.

Immune Response to Parasitic Infections - Immunity to Helminths and Novel Therapeutic Approaches: Immunity to Helminths and Novel Therapeutic Approaches

Immune Response to Parasitic Infections - Immunity to Helminths and Novel Therapeutic Approaches: Immunity to Helminths and Novel Therapeutic Approaches
by Bentham Science Publishers


This volume covers research on the interaction of major helminth parasites with the immune system. The main focus of the e-book is the ability of helminths to subvert host immune responses, on the one hand. On the other hand, the immunological armamentarium of the host against invading parasites is described also in the light of new findings on innate and adaptive immunity. These include the discovery of a new category of lymphocytes, innate lymphoid cells, and the role of T helper cels such as Th1, Th2 and Th3 cells, T regulatory (Treg) and Th17 cells in helminth diseases and inflammation. The balance between these two T cell subsets during the various stages of helminth diseases is also discussed. The book concludes with a review of new therapeutic approaches to combat helminth...

Immune response

Immune response
by Richard Helfrich (Author), James Cordell (Author)


179 pages

Genetics of the Immune Response (Nobel Foundation Symposia)

Genetics of the Immune Response (Nobel Foundation Symposia)
by Erna Moller (Editor)


The 55th Nobel Symposium entitled "Genetics of the Immune Response" took place in Saltsjobaden, Sweden, June 15 - 17, 1982. The topic was selected for several reasons, such as the rapid progress in the genetic analysis of immunoglobulin and MHC genes and the elucidation of the mechanism of switch to different immunoglobulin classes and subclasses. The genetic advances formed a basis for discussions of problems relating to regulation of T cell subsets, mechanisms of activation and regulation of B cell differentiation and an analysis of the network hypothesis. The format of the symposium was arranged so as to include two sessions in the morning and two in the afternoon. Each session was introduced by one speaker, followed by free discussion. The intro­ ductory lectures are included in the...

Molecular Mechanisms of Immune Responses in Insects

Molecular Mechanisms of Immune Responses in Insects
by P.T. Brey (Editor), D.E. Hultmark (Editor)


Insects are the most numerous and diverse group of animals on earth, not only in number of individuals, but also in number of species. They inhabit virtually all terrestrial and freshwater environments, where they must protect themselves from an array of commensal, pathogenic and parasitic organisms that share the same ecological niches.
Since the early 20th century, scientists have been intrigued by how insects defend themselves against microbial attack. We are currently witnessing a break-through in our understanding of the mechanisms governing immune reactions in insects. Molecular Mechanisms of Immune Responses in Insects covers various aspects of these mechanisms starting with a historical chapter on the origins of insect immunity. There are also chapters that cover...

© 2017 BrightSurf.com